---
id: nocardia-upper-lobe-cavitation_133
category: radiology
tags: [nocardia, cavitation, upper-lobe, chest-radiology, CT, immunocompromised, mimics-TB]
deck: Infectious Diseases
created: 2025-11-11
modified: 2025-11-11
---

## Nocardia - Upper Lobe Cavitation (Mimics TB)

**Q:** What are the characteristic CT findings of pulmonary Nocardia infection, and how does it mimic tuberculosis in immunocompromised hosts?

**A:**

## DEFINITION

**Nocardia:** Aerobic **Gram-positive**, **weakly acid-fast** filamentous bacterium causing pulmonary and disseminated infections in immunocompromised hosts.

**Species:** *Nocardia asteroides* complex (most common), *N. brasiliensis*, *N. farcinica*, *N. nova*

**Key Point:** **Nocardia = immunocompromised + upper lobe cavitation** (mimics TB)

---

## CT FINDINGS

**Hallmark: Upper Lobe Cavitation (Mimics TB)**

**Classic Pattern:**
- **Consolidation with cavitation** (thick-walled, irregular)
- **Upper lobe predominance** (50-70% of cases)
- **Single or multiple cavities**
- **Nodules** (single or multiple, 1-5cm)
- **Irregular margins** (spiculated, mass-like)

**Key Point:** **Upper lobe cavitary disease in immunocompromised = Nocardia vs TB vs fungal**

---

## IMAGING PATTERNS

**Mnemonic: "NOCARDIA"**

**N**odules (single or multiple, irregular margins)
**O**ften immunocompromised (transplant, steroids, HIV)
**C**avitation (thick-walled, upper lobes)
**A**bscess formation (parenchymal, brain)
**R**eticulonodular pattern (interstitial involvement)
**D**issemination (hematogenous - brain, skin, bone)
**I**rregular margins (spiculated, mass-like)
**A**cid-fast (weakly) - key diagnostic clue

---

## SPECIFIC CT PATTERNS

### **1. Consolidation with Cavitation (Most Common):**

**Characteristics:**
- **Upper lobe predominance** (50-70%)
- **Thick-walled cavities** (>4mm, irregular)
- **Surrounding consolidation**
- **Air-fluid levels** (may be present)
- **Mimics TB or lung abscess**

**Key Point:** **Thick-walled upper lobe cavities = TB, Nocardia, fungi** (context determines)

---

### **2. Nodules/Masses:**

**Characteristics:**
- **Single or multiple nodules** (1-5cm)
- **Irregular, spiculated margins** (mimics malignancy)
- **May cavitate** (central necrosis)
- **Variable distribution** (upper lobe > lower lobe)

**Key Point:** **Spiculated lung mass in immunocompromised = biopsy** (exclude malignancy, Nocardia, fungi)

---

### **3. Reticulonodular Pattern:**

**Characteristics:**
- **Interstitial infiltrates** (fine reticular or reticulonodular)
- **Bilateral, diffuse**
- **May progress to consolidation**

**Key Point:** **Diffuse reticulonodular in immunocompromised = PCP, Nocardia, viral, fungal**

---

### **4. Pleural Involvement:**

**Characteristics:**
- **Pleural effusion** (20-30% of cases, usually small)
- **Empyema** (if rupture into pleural space)
- **Chest wall extension** (direct invasion through pleura)

**Key Point:** **Chest wall mass in immunocompromised with lung disease = Nocardia, actinomycosis, Aspergillus**

---

## MIMICS TUBERCULOSIS

**Why Nocardia Mimics TB:**

| **Feature** | **Nocardia** | **Tuberculosis** |
|-------------|--------------|------------------|
| **Location** | **Upper lobe predominance** | **Upper lobe predominance** |
| **Cavitation** | **Thick-walled, irregular** | **Thick-walled, irregular** |
| **Immune status** | **Immunocompromised** | **Both (HIV, immunocompromised)** |
| **Staining** | **Weakly acid-fast** | **Strongly acid-fast** |
| **Dissemination** | **Brain, skin, bone** | **Miliary, CNS, bone** |
| **Treatment response** | **TMP-SMX (months)** | **RIPE (months)** |

**Key Difference:** **Nocardia = weakly acid-fast** | **TB = strongly acid-fast**

**Key Point:** **Upper lobe cavitary disease in immunocompromised = AFB stain + culture** (distinguish Nocardia vs TB)

---

## RISK FACTORS (HOST)

**Mnemonic: "TRANSPLANT"**

**T**ransplant recipients (solid organ, hematopoietic) - **highest risk**
**R**heumatologic disease (lupus, on immunosuppression)
**A**IDS (HIV CD4 <250)
**N**eoplasm (lymphoma, leukemia, on chemotherapy)
**S**teroids (high-dose, prolonged >15mg/day x 1 month)
**P**ulmonary disease (COPD, alveolar proteinosis, bronchiectasis)
**L**iver cirrhosis (advanced)
**A**lcoholism (chronic)
**N**eutropenia (prolonged)
**T**NF-α inhibitors (biologics)

**Key Point:** **Transplant recipients = highest risk** (especially in first 6 months post-transplant)

---

## DISSEMINATION PATTERN

**Hematogenous Dissemination (30-50% of pulmonary cases):**

**Mnemonic: "BRAIN SKIN BONE"**

**BRAIN** (most common, 20-40% of cases):
- **Brain abscess** (single or multiple)
- **Ring-enhancing lesions**
- **Mimics toxoplasmosis, fungal abscess**
- **Always image brain** in pulmonary nocardiosis

**SKIN** (10-20%):
- **Subcutaneous abscesses**
- **Cellulitis**
- **Mycetoma** (if primary cutaneous)

**BONE** (5-10%):
- **Osteomyelitis**
- **Vertebral involvement** (mimics TB spondylitis)

**Key Point:** **Always obtain brain MRI** in pulmonary nocardiosis (rule out CNS dissemination)

---

## CLINICAL PRESENTATION

**Pulmonary Nocardiosis:**
- **Subacute onset** (weeks to months)
- **Fever** (50-80%)
- **Cough** (productive or nonproductive)
- **Chest pain** (pleuritic if pleural involvement)
- **Weight loss, night sweats** (mimics TB)
- **Dyspnea** (less common)

**Physical Exam:**
- **Often nonspecific**
- **Crackles** (if consolidation)
- **Dullness to percussion** (if effusion)
- **May have signs of disseminated disease** (skin lesions, neurologic findings)

**Key Point:** **Subacute pulmonary symptoms in immunocompromised = broad differential** (TB, Nocardia, fungi, malignancy)

---

## DIAGNOSIS

**Microscopy:**
- **Gram stain:** Gram-positive, **branching, beaded filaments**
- **Modified acid-fast stain:** **Weakly acid-fast** (distinguishes from TB)
- **Appearance:** Delicate, branching filaments (1-5 μm width)

**Culture:**
- **Aerobic culture** (not anaerobic)
- **Sabouraud agar** (grows on fungal media)
- **Slow-growing** (3-7 days, may take up to 2-4 weeks)
- **Chalky colonies** (white, raised, dry)

**Molecular Testing:**
- **16S rRNA gene sequencing** (species identification)
- **PCR** (rapid detection, not widely available)

**Key Point:** **Weakly acid-fast branching filaments = Nocardia** (vs TB strongly acid-fast)

---

## DIFFERENTIAL DIAGNOSIS

**Upper Lobe Cavitary Disease:**

**Mnemonic: "CAVITY"** (same as TB card)

**C**ancer (squamous cell carcinoma)
**A**spergillosis, lung abscess
**V**asculitis (GPA/Wegener's)
**I**nfection (**TB, Nocardia, fungi, Staph**)
**T**hromboembolic (septic emboli)
**Y**outh (congenital - sequestration, cysts)

**Key Point:** **Immunocompromised + upper lobe cavity = TB > Nocardia > Aspergillus > malignancy**

---

## TREATMENT

**First-Line:**
- **Trimethoprim-sulfamethoxazole (TMP-SMX)** 5-10 mg/kg IV/PO q8-12h (TMP component)
- **Duration:**
  - **Pulmonary only (immunocompetent):** 6-12 months
  - **Pulmonary only (immunocompromised):** 12 months
  - **Disseminated or CNS involvement:** 12-18 months

**Alternative Regimens (if sulfa allergy or resistance):**
- **Imipenem** 500mg IV q6h OR **meropenem** 1g IV q8h
- **Amikacin** 15 mg/kg IV daily (for severe disease, combination therapy)
- **Linezolid** 600mg PO/IV q12h
- **Ceftriaxone** or **cefotaxime** (variable susceptibility)

**Combination Therapy:**
- **Severe disease or CNS involvement:** TMP-SMX + imipenem (or amikacin)
- **Duration:** 3-6 weeks IV, then oral TMP-SMX

**Key Point:** **TMP-SMX for 12 months minimum** (immunocompromised) | **Always treat disseminated disease for ≥12-18 months**

---

## PROGNOSIS

**Mortality:**
- **Pulmonary nocardiosis alone:** 10-20% mortality
- **Disseminated disease:** 40-50% mortality
- **CNS involvement:** 50-60% mortality (despite treatment)

**Predictors of Poor Outcome:**
- **CNS involvement**
- **Delayed diagnosis** (>1 month from symptom onset)
- **Immunosuppression** (transplant, AIDS, high-dose steroids)
- ***N. farcinica* species** (more virulent, multidrug-resistant)

**Key Point:** **Early diagnosis + prolonged treatment = improved survival** (especially CNS disease)

---

**Clinical Pearls:**
- **Nocardia = immunocompromised + upper lobe cavitation** (mimics TB)
- **Weakly acid-fast branching filaments** (vs TB strongly acid-fast)
- **Transplant recipients = highest risk** (especially first 6 months)
- **Dissemination to brain in 20-40%** (always image brain with MRI)
- **Spiculated lung mass mimics malignancy** (biopsy essential)
- **TMP-SMX = first-line treatment** (5-10 mg/kg TMP q8-12h)
- **Duration: 6-12 months (immunocompetent pulmonary), 12 months (immunocompromised pulmonary), 12-18 months (disseminated/CNS)**
- **Slow-growing on culture** (3-7 days, may take weeks)
- **Modified acid-fast stain essential** (distinguishes from TB)
- **CNS disease = worst prognosis** (50-60% mortality)

**Media:**

**Image 1 - Pulmonary Nocardia (Upper Lobe Cavitation):**

*CT chest showing thick-walled cavitary lesions in the right upper lobe with surrounding consolidation and irregular margins in an immunocompromised patient (post-transplant). Mimics tuberculosis but patient has weakly acid-fast branching filaments on modified AFB stain.*

**Image 2 - Nocardia Brain Abscess (Dissemination):**

*Brain MRI showing multiple ring-enhancing lesions (brain abscesses) in a patient with pulmonary nocardiosis. Always image brain in pulmonary nocardiosis to rule out CNS dissemination (occurs in 20-40%).*

**Additional Resources:**
- **Radiopaedia.org:** Search "pulmonary nocardiosis," "nocardia brain abscess"
- **PMC3977476:** Pulmonary nocardiosis imaging patterns
- **PMC7313458:** Nocardia in transplant recipients

**Sources:** [Radiopaedia - Nocardiosis], [IDSA Guidelines - Opportunistic Infections in Transplant], [PMC3977476]
